What We Got Wrong About GLP-1s (And What's Actually Right)
Mark Hyman, MD — What We Got Wrong About GLP-1s (And What's Actually Right)
Channel: Mark Hyman, MD · Our label: Physician — functional medicine · Source: youtube.com/watch?v=U7kNGpeNWOw
What this video covers
I’ve changed my opinion over the years on this. I at first I was skeptical and I and I’ve changed my position » and I think the one thing that this [music] whole journey has showed all of us is that metabolic health is the core of everything. These peptides improve metabolic health overall. And when we see metabolic health improve, we see all kinds of benefits across the board regardless of weight loss.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- These peptides improve metabolic health overall.
Yeah, I think that’s a really important framework for people to understand GLP-1s [music] because a lot of doctors just prescribe them.
- I think that’s a really important framework for people to understand jumpy ones because a lot of doctors just prescribe them.
- But this new study came out in gastronurology in 2025 and it was a better done study and the finding was no significant increase in pancreatitis bowel obstruction or gallbladder inflammation.
So, Tina, let’s talk about what people should think about before they want to start GLP-1s and what kind of blood tests or metabolic markers should people look at before prescribing.
- And I I’ll say though, the clients I’ve got a few clients I work with who are getting prescriptions from their doctors and the zepp seems to be working better than the compounded for them for weight loss.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.